HIGHLIGHTS
- who: January and collaborators from the Alexandria University, Egypt Chinese Medical Sciences, China have published the research work: Exploring the molecular mechanism of notoginsenoside R1 in sepsis-induced cardiomyopathy based on network pharmacology and experiments validation, in the Journal: (JOURNAL)
- what: This is the first study to investigate the mechanism of NG-R1 for the treatment of sepsis-induced myocardial injury using network pharmacology, molecular docking, and experimental validation.
- how: Postoperatively the authors observed the 7 days survival rate of mice in each group and the results showed that the 7 days survival . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.